This finding fits with the prerequisite of CD1d expression by tumors to promote efficient iNKT cell-mediated killing, which has been previously reported in humans in the context of CD1d-expressing lymphomas [26, 37, 38], and in mice with tumor models transfected with CD1d [39, 40]. The gene discussed is CD1D; the disease is neoplasm.